BeOne Medicines Ltd ADR

ONCNASDAQ · USD
350.84USD0.00 (-0.75%)
569

BeOne Medicines Ltd ADR (ONC) Covered Calls

As of September 17, 2026, ONC has 47 covered call opportunities in the coming three months. Return ranges from 2.0 to 53.1% until expiration. Annualized return ranges from 21.5 to 4,826.6%. The nearest expiration is September 18, 2026. Maximum potential profit is $18,754.

Read more

Running ONC covered calls helps you generate consistent income from BeOne Medicines Ltd ADR's shares you already own, turning a long stock position into a yield-producing asset. A covered call on BeOne Medicines Ltd ADR involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ONC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ONC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ONC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given BeOne Medicines Ltd ADR covered call is worth writing.

BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambridge, Massachusetts—with operations spanning over 45 countries across six continents—the company rebranded as BeOne in late 2024 and redomiciled to Basel, Switzerland in 2025. BeOne has established itself as a leader in immuno-oncology and targeted therapies, with key assets including Tevimbra (tislelizumab), a PD-1 monoclonal antibody approved for multiple cancer indications globally, and Brukinsa (zanubrutinib), a Bruton's tyrosine kinase (BTK) inhibitor that surpassed $1.3 billion in annual sales and is approved in major markets such as the U.S., Europe, and China.

The company’s strategy combines internal R&D with the development of assets sourced from external partnerships, driving a robust pipeline across hematologic malignancies and solid tumors.

Income-focused investors, long-term ONC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ONC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best BeOne Medicines Ltd ADR covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile12.70% Subdued
  • Market cap (M$)36,582
  • 52 weeks high-8.92%
  • 52 weeks low38.15%
  • Analyst recommendationStrong Buy
    1.28
  • Target price$435.32
    24.08% above the current stock price
  • Dividend
  • Payout ratio0.00%
  • Earnings date2026-11-05
  • P/E61.65
  • Future P/E34.95
  • EPS (ttm)5.69
  • EPS growth next 5 years73.39%

As of September 17, 2026

2026-09-181400.0013.170.205.004674.0013.224826.60-0.06+0.14504.80
2026-09-181360.001.850.604.10714.002.02737.31-0.17+0.3183.50
2026-11-2064450.0027.310.105.009664.0027.34155.93-0.03+0.1024.90
2026-11-2064440.0024.481.005.008754.0024.77141.25-0.28+0.1114.00
2026-10-1629390.0010.341.005.003754.0010.62133.67-0.28+0.1704.00
2026-11-2064430.0021.652.006.207854.0022.22126.73-0.57+0.15524.20
2027-02-19155540.0052.781.005.0018754.0053.06124.94-0.28+0.0804.00
2027-02-19155520.0047.122.005.0016854.0047.68112.29-0.57+0.0903.00
2026-11-2064420.0018.833.007.306954.0019.67112.20-0.85+0.1894.30
2026-10-1629380.007.513.706.903024.008.56107.68-1.05+0.2653.20

As of September 17, 2026

Sell covered calls with the data behind you

Find the best ONC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial